Soft M&A Market in H1 2014 as Number of Deals in Omics/MDx Space Drops 33 Percent | GenomeWeb

NEW YORK (GenomeWeb) – Mergers and acquisitions in the omics and molecular diagnostics space stayed soft through the first half of the year as the number of deals dropped 33 percent year over year.

Through the six months ending June 30, 16 M&A deals were either announced or completed, down from 24 in the first half of 2013. Sequentially, the drop was 30 percent from 23 deals in the second half of 2013.

The numbers include those transactions in which an entire company was acquired, but does not include the purchases of assets or divisions only.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: map of UV-induced damage in yeast genome, comparative epigenomics uncovers plant lacking key DNA methyltransferase enzyme, and more.

Researchers kick off their second Queer in STEM survey to examine what can make STEM careers welcoming, Wired reports.

A startup company is offering a test to analyze soil samples from farms for pathogens.

Prosecutors seek to introduce evidence from low-template DNA analysis in a murder case in upstate New York, the New York Times reports.